GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » China Shineway Pharmaceutical Group Ltd (OTCPK:CSWYY) » Definitions » Cash Flow for Dividends

China Shineway Pharmaceutical Group (China Shineway Pharmaceutical Group) Cash Flow for Dividends : $-44.3 Mil (TTM As of Dec. 2023)


View and export this data going back to 2008. Start your Free Trial

What is China Shineway Pharmaceutical Group Cash Flow for Dividends?

China Shineway Pharmaceutical Group's cash flow for dividends for the six months ended in Dec. 2023 was $-11.6 Mil. Its cash flow for dividends for the trailing twelve months (TTM) ended in Dec. 2023 was $-44.3 Mil.

Note: A negative number here means the payment of dividends. When pays more dividends, the absolute value gets bigger.

China Shineway Pharmaceutical Group's quarterly payment of dividends increased from Dec. 2022 ($-11.9 Mil) to Jun. 2023 ($-32.7 Mil) but then declined from Jun. 2023 ($-32.7 Mil) to Dec. 2023 ($-11.6 Mil).

China Shineway Pharmaceutical Group's annual payment of dividends declined from Dec. 2021 ($-71.1 Mil) to Dec. 2022 ($-34.7 Mil) but then increased from Dec. 2022 ($-34.7 Mil) to Dec. 2023 ($-44.4 Mil).


China Shineway Pharmaceutical Group Cash Flow for Dividends Historical Data

The historical data trend for China Shineway Pharmaceutical Group's Cash Flow for Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China Shineway Pharmaceutical Group Cash Flow for Dividends Chart

China Shineway Pharmaceutical Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cash Flow for Dividends
Get a 7-Day Free Trial Premium Member Only Premium Member Only -35.51 -36.93 -71.13 -34.67 -44.43

China Shineway Pharmaceutical Group Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Cash Flow for Dividends Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -46.25 -23.69 -11.92 -32.70 -11.64

China Shineway Pharmaceutical Group Cash Flow for Dividends Calculation

Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Cash Flow for Dividends for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was $-44.3 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


China Shineway Pharmaceutical Group Cash Flow for Dividends Related Terms

Thank you for viewing the detailed overview of China Shineway Pharmaceutical Group's Cash Flow for Dividends provided by GuruFocus.com. Please click on the following links to see related term pages.


China Shineway Pharmaceutical Group (China Shineway Pharmaceutical Group) Business Description

Traded in Other Exchanges
Address
Luan Cheng, Hebei Province, Shijiazhuang, CHN
China Shineway Pharmaceutical Group Ltd is an investment holding company in the People's Republic of China. Principally, it is engaged in the research, development, manufacturing, and trading of modern Chinese medicines. The company's products comprise injection, soft capsule, granule, and others of which injection generates maximum revenue to the company.

China Shineway Pharmaceutical Group (China Shineway Pharmaceutical Group) Headlines